Robert L Levy

US Patent:

7860796, Dec 28, 2010

Filed:

Jan 27, 2006

Appl. No.:

11/341309

Inventors:

Robert D. Levy - New Rochelle NY, US

Assignee:

MarketAxess Holdings, Inc. - New York NY

International Classification:

G06Q 40/00

US Classification:

705 45, 705 37, 705 64, 705 36 R, 705 35

Abstract:

Methods and systems for trading financial or commodity assets are presented. In particular, the invention relates to a trading system and method that operates with third party data and a Third Party Inside Market to promote fair and orderly transactions. In some embodiments, a client order or client bid/offer is protected by automated order protection (AOP), which may be a set of rules or specifications that can modify a client's order. In certain embodiments, an average weighted price function is used to protect a client order that might be larger than the best bid/offer. In other embodiments, an autofill, a tie-breaking, and a wait-for-follow process can be used to promote trading opportunities for dealers and/or clients.

US Patent:

20070128184, Jun 7, 2007

Filed:

Aug 30, 2006

Appl. No.:

11/512412

Inventors:

Eckhard Podack - Miami FL, US
Vadim Deyev - Miami FL, US
Robert Levy - Cooper City FL, US

International Classification:

A61K 39/395
C07K 16/46
C07K 16/28

US Classification:

424143100, 530388220, 424178100, 530391100

Abstract:

It is an object of the invention to provide novel compositions and methods utilizing immunomodulating agents that can either stimulate or indirectly augment the immune system or in other cases have an immunosuppressive effect. TNFR25 agonists disclosed herein have an anti-inflammatory and healing effect. They can be used, among other things, to treat disease caused by asthma and chronic inflammation such as for example inflammatory bowel diseases including ulcerative colitis and Crohn's Disease. TNFR25 antagonists disclosed herein are capable of inhibiting CD8 T cell-mediated cellular immune responses and can for example, mitigate organ or tissue rejection following a tissue transplantation. TNFR25 agonists disclosed herein represent biological response modifiers that alter the interaction between the body's cellular immune defenses and cancer cells to boost, direct, or restore the body's ability to fight the cancer when given with tumor vaccines. TNFR25 specific immunotoxins disclosed herein are also capable of increasing the effectiveness of a chemotherapeutic regimen by depleting a cancer patient of naturally occurring immunosuppressive cells.

US Patent:

20110243951, Oct 6, 2011

Filed:

Aug 3, 2009

Appl. No.:

12/534228

Inventors:

Eckhard R. Podack - Coconut Grove FL, US
Vadim Deyev - Miami FL, US
Robert Levy - Cooper City FL, US

Assignee:

University of Miami - Miami FL

International Classification:

A61K 39/395
A61P 29/00
A61P 11/00

US Classification:

4241451, 4241581

Abstract:

It is an object of the invention to provide novel compositions and methods utilizing immunomodulating agents that can either stimulate or indirectly augment the immune system or in other cases have an immunosuppressive effect. TNFR25 agonists disclosed herein have an anti-inflammatory and healing effect. They can be used, among other things, to treat disease caused by asthma and chronic inflammation such as for example inflammatory bowel diseases including ulcerative colitis and Crohn's Disease. TNFR25 antagonists disclosed herein are capable of inhibiting CD8 T cell-mediated cellular immune responses and can for example, mitigate organ or tissue rejection following a tissue transplantation. TNFR25 agonists disclosed herein represent biological response modifiers that alter the interaction between the body's cellular immune defenses and cancer cells to boost, direct, or restore the body's ability to fight the cancer when given with tumor vaccines. TNFR25 specific immunotoxins disclosed herein are also capable of increasing the effectiveness of a chemotherapeutic regimen by depleting a cancer patient of naturally occurring immunosuppressive cells.

US Patent:

20120321645, Dec 20, 2012

Filed:

Apr 27, 2012

Appl. No.:

13/457583

Inventors:

Eckhard R. Podack - Coconut Grove FL, US
Vadim Deyev - Miami FL, US
Robert Levy - Cooper City FL, US

Assignee:

UNIVERSITY OF MIAMI - Coral Gables FL

International Classification:

A61K 39/00
A61P 37/04
A61P 35/00
A61K 39/395

US Classification:

4241731, 4241841, 4242771

Abstract:

Compositions and methods utilizing immunomodulating agents can either stimulate or indirectly augment the immune system or have an immunosuppressive effect. TNFR25 agonists disclosed herein have an anti-inflammatory and healing effect. They can be used to treat disease caused by asthma and chronic inflammation such as inflammatory bowel diseases including ulcerative colitis and Crohn's Disease. TNFR25 antagonists disclosed herein are capable of inhibiting CD8 T cell-mediated cellular immune responses and can for example, mitigate organ or tissue rejection following a tissue transplantation.

US Patent:

48448443, Jul 4, 1989

Filed:

Apr 27, 1988

Appl. No.:

7/186816

Inventors:

Robert M. Levy - New York NY

International Classification:

B01F 304

US Classification:

261 62

Abstract:

An improvement is disclosed for a flare seal system of the type which includes a flare seal drum containing a body of liquid at a predetermined level and a waste gas inlet conduit extending vertically into the liquid body and having an opening beneath the liquid level, whereby gases discharging from the inlet conduit pass through the liquid body before discharging from the drum to a flare stack. The improvement enables the reduction of gas pulsing from the seal drum, and includes flap valve means pivotally mounted at the wall of the inlet conduit. The flap valve is openable at a point beneath the liquid level, and includes means to bias the valve to a closed position. The inlet gas flow pressure acts against the bias to open the valve, to enable gas flow into the liquid and thence to the flare stack.

US Patent:

D4372107, Feb 6, 2001

Filed:

May 7, 1999

Appl. No.:

D/104593

Inventors:

Dominic A. Borotto - Hollywood FL
Robert L. Levy - North Miami Beach FL
Bill E. Kushner - Aventura FL

Assignee:

Taco Metals, Inc. - Miami FL

International Classification:

0808

US Classification:

D 8396

US Patent:

D4513649, Dec 4, 2001

Filed:

Jun 12, 2000

Appl. No.:

D/124778

Inventors:

Dominic A. Borotto - Hollywood FL
Robert L. Levy - North Miami Beach FL
Bill E. Kushner - Aventura FL

Assignee:

Taco Metals, Inc. - Miami FL

International Classification:

0806

US Classification:

D 8323

US Patent:

D4513711, Dec 4, 2001

Filed:

Jun 12, 2000

Appl. No.:

D/124777

Inventors:

Dominic A. Borotto - Hollywood FL
Robert L. Levy - North Miami Beach FL
Bill E. Kushner - Aventura FL

Assignee:

Taco Metals, Inc. - Miami FL

International Classification:

0808

US Classification:

D 8396